Virus Protease

CAS No.	Product Name	Inquiry
2910757-21-8	NS2B/NS3-IN-5
2910757-30-9	NS2B/NS3-IN-4
2977251-02-6	HCVcc-IN-2
2977251-08-2	HCVcc-IN-1
299919-79-2	SARS-CoV-2-IN-33
3010895-54-9	CYP2C1/CYP2C19-IN-2
3010940-08-3	NS2B/NS3-IN-2
3035421-16-7	NS2B/NS3-IN-7
30462-35-2	Theaflavin 3,3'-digallate Theaflavin 3,3'-digallate is a flavonoid isolated from Black tea. It is a good antitumor agent as well.
314062-80-1	BTA-188
3156-41-0	SARS-CoV-2 3CLpro-IN-15
329221-38-7	AX20017 AX20017 is a highly selective PknG inhibitor. It acts by blocking the proliferation of M. tuberculosis. AX20017 is shown to completely inactivate PknG-mediated blockage of lysosomal transfer and degradation of M. bovis BCG in macrophages at concentrations (10μM or higher) that does not otherwise affect the growth of BCG outside its infected host.
343565-99-1	AG-7404 AG-7404 is an inhibitor of picornaviral 3C protease against a large panel of programmatically important poliovirus strains. AG-7404 was fully active against all V-073-resistant variants with EC50 values ranging from 0.218 to 0.819 μM.
344298-93-7	L-Lysine-d8 hydrochloride L-Lysine-[d8] hydrochloride is a labelled salt of L-Lysine. L-Lysine is an essential amino acid obtained from red meats and fish. Lysine inhibits HSV growth via knocking out arginine. It is also used in the labelling of human bone marrow mesenchymal stem cells for analysis.
3486-67-7	Palmatine Palmatine could potentially be developed for the treatment of flavivirus infections.Palmatine is an inhibitor of dopamine generation.
358730-86-6	4-Phenylbutyric Acid-[d11] 4-Phenylbutyric acid-d11 (4-PBA-d11) is the deuterium labeled 4-Phenylbutyric acid. 4-Phenylbutyric acid (4-PBA) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research.
420090-97-7	Flaviviruses-IN-3
432499-63-3	4E2RCat 4E2RCat is an inhibitor of eIF4E-eIF4G interaction with an IC50 of 13.5 μM.
437-64-9	Genkwanin Genkwanin isolated from the herbs of Lobelia chinensis. It is transported by both passive diffusion and multidrug resistance protein (MDR)-mediated efflux mechanisms.
476-28-8	Lycorine Source from bulbus of Lycoris radiata (L. Herit.) Herb. Anti-cancer effects of Lycorine were dependent on STAT expression. We suggest that Lycorine is a potential therapeutic in prostate cancer. Inhibition of HDAC activity is responsible for at least part of the induction of cell-cycle arrest in the G0/G1 phase by Lycorine and provide a mechanistic framework for further exploring the use of Lycorine as a novel antitumor agent.

※ Please kindly note that our services are for research use only.